# The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy

> **NCT01880372** · NA · TERMINATED · sponsor: **Ferris State University** · enrollment: 1 (actual)

## Conditions studied

- Moderate Non-proliferative Diabetic Retinopathy

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha Lipoic Acid

## Key facts

- **NCT ID:** NCT01880372
- **Lead sponsor:** Ferris State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low number of patients enrolled
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01880372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01880372, "The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01880372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*